[144] Confluent, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 notice from Confluent, Inc. (CFLT) reports a proposed sale of 1,626,667 common shares through Morgan Stanley Smith Barney LLC on NASDAQ. The filing lists an aggregate market value of $32,923,740.08 and reports total shares outstanding of 291,931,187. The shares were acquired as Founders Shares on July 21, 2020 from the issuer and no securities of the issuer were reported sold by the seller in the past three months. The notice includes the seller's representation that they are not aware of undisclosed material adverse information and indicates the filing is live.

Positive

• Filing complies with Rule 144 notification requirements and names the executing broker-dealer
• Shares identified as Founders Shares with acquisition date clearly disclosed (07/21/2020)

Negative

• Proposed sale size of 1,626,667 shares with aggregate market value of $32,923,740.08 could represent meaningful insider liquidity
• No trading-plan date disclosed (no Rule 10b5-1 plan adoption date provided in the remarks)

Insights

Securities Analyst

TL;DR: A founder is seeking to sell a significant block of Confluent shares valued at ~$32.9M; trade mechanics are disclosed via Form 144.

The filing documents a proposed brokered sale of 1,626,667 common shares through Morgan Stanley Smith Barney on NASDAQ with an aggregate market value of $32,923,740.08. These shares are identified as Founders Shares acquired from the issuer on July 21, 2020. The seller reports no other sales in the prior three months. From an execution perspective, the filing meets Rule 144 notification requirements and provides counterparty routing via a named broker-dealer. This is a routine insider liquidity event rather than an operational disclosure; it does not by itself change the company’s financials but may have short-term trading implications depending on order execution and market liquidity.

Corporate Governance Expert

TL;DR: Governance disclosure is complete for a founder sale; the seller affirms absence of undisclosed material information.

The Form 144 shows the seller relied on public disclosure and made the required certification regarding material information. The shares are founders’ equity originating from July 21, 2020, and the planned sale is routed through a recognized broker-dealer. The filing contains no indication of a Rule 10b5-1 trading plan date or any special transfer restrictions. As filed, the document satisfies procedural governance transparency expected for insider liquidity events but does not provide context on the seller’s role or motivations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1626667	32923740.08	291931187	09/09/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/21/2020	Founders Shares	Issuer			1626667	07/21/2020	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Confluent's (CFLT) Form 144 report?

The Form 144 reports a proposed sale of 1,626,667 common shares via Morgan Stanley Smith Barney with an aggregate market value of $32,923,740.08 on NASDAQ.

When were the shares being sold originally acquired?

The shares were acquired as Founders Shares on July 21, 2020 from the issuer.

Has the seller reported other sales of Confluent stock in the past three months?

No. The filing states "Nothing to Report" for securities sold during the past three months.

Through which broker will the Confluent shares be sold?

The filing names Morgan Stanley Smith Barney LLC, 1 New York Plaza, 8th Floor, New York, NY 10004 as the broker.

Does the filing indicate the seller knows of undisclosed material information?

By signing the notice, the seller represents they do not know any material adverse information about the issuer that has not been publicly disclosed.